摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-bis[(2,5-dimethoxyphenyl)(phenyl)phosphino]ethane | 1064156-46-2

中文名称
——
中文别名
——
英文名称
1,2-bis[(2,5-dimethoxyphenyl)(phenyl)phosphino]ethane
英文别名
(2,5-Dimethoxyphenyl)-[2-[(2,5-dimethoxyphenyl)-phenylphosphanyl]ethyl]-phenylphosphane
1,2-bis[(2,5-dimethoxyphenyl)(phenyl)phosphino]ethane化学式
CAS
1064156-46-2
化学式
C30H32O4P2
mdl
——
分子量
518.529
InChiKey
RTUPSASRVQOJJL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.8
  • 重原子数:
    36
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    36.9
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • [EN] METHOD FOR INCREASING THE ENANTIOMERIC EXCESS OF CHIRAL PHOSPHINE OXIDES, SULPHIDES, IMIDES AND BORANES<br/>[FR] PROCÉDÉ POUR AUGMENTER L'EXCÈS ÉNANTIOMÉRIQUE DES OXYDES, DES SULFURES, ET DES IMIDES DE PHOSPHINE AINSI QUE DES PHOSPHINE-BORANES CHIRAUX
    申请人:CELTIC CATALYSTS LTD
    公开号:WO2010004278A1
    公开(公告)日:2010-01-14
    The present invention relates to a method for increasing the enantiomeric excess of a chiral phosphine oxide, a chiral phosphine sulphide, a chiral phosphine-borane and a chiral phosphine imide said method comprising the steps of: (a) contacting said chiral phosphine oxide, sulphide, imide or borane with a solvent to form a slurry; (b) partitioning the phosphine oxide, sulphide, imide or borane either into the solvent or as an insoluble product; and (c) optionally, isolating the partitioned phosphine oxide, sulphide, imide or borane.
    本发明涉及一种用于增加手性亚磷酰氧化物、手性亚磷酰硫、手性亚磷酰-硼烷和手性亚磷酰亚胺的对映体过量值的方法,所述方法包括以下步骤:(a)将所述手性亚磷酰氧化物、硫、亚胺或硼烷与溶剂接触以形成悬浮液;(b)将亚磷酰氧化物、硫、亚胺或硼烷分配到溶剂中或作为不溶产物;以及(c)可选地,分离出分配的亚磷酰氧化物、硫、亚胺或硼烷。
  • CHIRAL PHOSPHOROUS COMPOUNDS
    申请人:Gilheany Declan
    公开号:US20100168456A1
    公开(公告)日:2010-07-01
    The present invention provides P-chiral compounds of general formulae (II) and (III): in formula (II) at least one of R 21 , R 25 , R 26 and R 30 is independently selected from CM alkyl, CF 3 , C 1-4 alkoxy, phenyl and benzyloxy and the remaining substituents selected from R 21 , R 25 , R 26 and R 30 are hydrogen; at least one of R 22, R 24, R 27 and R 29 are independently selected from C 1-14 alkyl, CF 3, C 1-14 alkoxy, phenyl and benzyloxy and the remaining substituents selected, from R 22 , R 24, R 27 and R 29 are hydrogen; and R 23 and R28 are independently selected from hydrogen, CM alkyl, CF 3 , C 1-14 alkoxy, phenyl and benzyloxy; in formula (III) at least one of R 21 , R 25 , R 26 and R 30 is independently selected from phenyl and benzyloxy and the remaining substituents selected from R 21 , R 25 , R— 26 and R 30 are hydrogen; and R 22 , R— 23 R 24, R 27 , R 28 and R 29 are independently selected from hydrogen, C 1-14 alkyl, CF 3 , C 1-14 alkoxy, phenyl and benzyloxy.
    本发明提供了一般式(II)和(III)的P-手性化合物:在式(II)中,R21、R25、R26和R30中至少有一个是独立选择的CM烷基,CF3,C1-4烷氧基,苯基和苄氧基,其余取代基选择自R21、R25、R26和R30为氢;R22、R24、R27和R29中至少有一个是独立选择的C1-14烷基,CF3,C1-14烷氧基,苯基和苄氧基,其余取代基选择自R22、R24、R27和R29为氢;R23和R28独立选择自氢,CM烷基,CF3,C1-14烷氧基,苯基和苄氧基;在式(III)中,R21、R25、R26和R30中至少有一个是独立选择的苯基和苄氧基,其余取代基选择自R21、R25、R-26和R30为氢;R22、R-23、R24、R27、R28和R29独立选择自氢,C1-14烷基,CF3,C1-14烷氧基,苯基和苄氧基。
  • CHIRAL DIPHOSPINES, METHODS FOR THEIR PREPARATION, TRANSITION METAL COMPLEXES COMPRISING THEM AND USE IN CHIRAL SYNTHESIS
    申请人:Celtic Catalysts Limited
    公开号:EP2139905A2
    公开(公告)日:2010-01-06
  • US8067642B2
    申请人:——
    公开号:US8067642B2
    公开(公告)日:2011-11-29
  • [EN] CHIRAL PHOSPHORUS COMPOUNDS<br/>[FR] COMPOSÉS CHIRAUX DU PHOSPHORE
    申请人:CELTIC CATALYSTS LTD
    公开号:WO2008117054A2
    公开(公告)日:2008-10-02
    [EN] The present invention provides P-chiral compounds of general formula (II) and (III): wherein at least one of R21, R25, R26 and R30 is independently selected from C1-4 alkyl, CF3, C1-4 alkoxy, phenyl and benzyloxy and the remaining substituents selected from R21, R25, R26 and R30 are hydrogen; at least one of R22, R24, R27 and R29 are independently selected from C1-4 alkyl, CF3, C1-4 alkoxy, phenyl and benzyloxy and the remaining substituents selected from R22, R24, R27 and R29 are hydrogen; and R23 and R28 are independently selected from hydrogen, C1-4 alkyl, CF3, C1-4 alkoxy, phenyl and benzyloxy; Formula (III): wherein at least one of R21, R25, R26 and R30 is independently selected from phenyl and benzyloxy and the remaining substituents selected from R21, R25, R26 and R30 are hydrogen; and R22, R23, R24, R27, R28 and R29 are independently selected from hydrogen, C1-4 alkyl, CF3, C1-4 alkoxy, phenyl and benzyloxy.wherein at least one of R21, R25, R26 and R30 is independently selected from phenyl and benzyloxy and the remaining substituents selected from R21, R25, R26 and R30 are hydrogen; and R22, R23, R24, R27, R28 and R29 are independently selected from hydrogen, C1-4 alkyl, CF3, C1-4 alkoxy, phenyl and benzyloxy.
    [FR] La présente invention concerne des composés chiraux P de formule générale (II) et (III) : dans lesquelles au moins un de R21, R25, R26 et R30 est indépendamment choisi parmi les groupes alkyle en C1-4, CF3, alcoxy en C1-4, phényle et benzyloxy et les autres substituants choisis parmi R21, R25, R26 et R30 sont un atome d'hydrogène ; au moins un de R22, R24, R27 et R29 est indépendamment choisi parmi les groupes alkyle en C1-4, CF3, alcoxy en C1-4, phényle et benzyloxy et les autres substituants choisis parmi R22, R24, R27 et R29 sont un atome d'hydrogène ; et R23 et R28 sont indépendamment choisis parmi un atome d'hydrogène, un groupe alkyle en C1-4, CF3, alcoxy en C1-4, phényle et benzyloxy ; Formule (III) : dans laquelle au moins un de R21, R25, R26 et R30 est indépendamment choisi parmi les groupes phényle et benzyloxy et les autres substituants choisis parmi R21, R25, R26 et R30 sont un atome d'hydrogène ; et R22, R23, R24, R27, R28 et R29 sont indépendamment choisis parmi un atome d'hydrogène, un groupe alkyle en C1-4, CF3, alcoxy en C1-4, phényle et benzyloxy, dans laquelle au moins un de R21, R25, R26 et R30 est indépendamment choisi parmi les groupes phényle et benzyloxy et les autres substituants choisis parmi R21, R25, R26 et R30 sont un atome d'hydrogène ; et R22, R23, R24, R27, R28 et R29 sont indépendamment choisis parmi un atome d'hydrogène, un groupe alkyle en C1-4, CF3, alcoxy en C1-4, phényle et benzyloxy.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐